GlassScriptPhysician profile
Brandon M Trumble
NPI 1972932853
$6,260.01
in general payments reported to CMS, 2019-2025
31 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $476 · 2023: $1,836 · 2024: $1,644 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,599 · Education: $53.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,598.70 |
| Education | $53.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $995.71 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $601.76 | 2022-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Neurocrine Biosciences, INC. | $488.09 | 2023-2025 | Ingrezza |
| Indivior INC. | $478.55 | 2022-2024 | Perseris, Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $424.93 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $407.85 | 2022-2025 | Austedo Xr, Austedo Xr, Uzedy |
| E.R. Squibb & Sons, L.L.C. | $373.60 | 2024-2025 | Cobenfy |
| Pfizer INC. | $313.66 | 2023-2025 | |
| Alkermes, INC. | $302.33 | 2023-2024 | Aristada, Lybalvi, Aristada Initio |
| Viiv Healthcare Company | $276.57 | 2024-2025 | Apretude |
| Corium, LLC | $214.93 | 2022-2023 | Azstarys |
| Janssen Pharmaceuticals, INC | $208.52 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Lundbeck LLC | $186.13 | 2023-2025 | Rexulti |
| Collegium Pharmaceutical, INC. | $164.82 | 2021-2025 | Xtampza, Belbuca |
| Takeda Pharmaceuticals U.S.A., INC. | $119.42 | 2022-2025 | Trintellix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $115.71 | 2023-2025 | Brixadi |
| Axsome Therapeutics, INC. | $93.61 | 2023-2024 | Auvelity |
| Merck Sharp & Dohme LLC | $73.87 | 2022-2023 | Belsomra |
| Supernus Pharmaceuticals, INC. | $66.79 | 2021-2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $51.69 | 2023-2024 | Jornay Pm |
| Avanir Pharmaceuticals, INC. | $49.59 | 2022 | |
| Protega Pharmaceutials INC | $37.64 | 2025 | Roxybond |
| Vanda Pharmaceuticals INC. | $32.55 | 2025 | Fanapt |
| Idorsia Pharmaceuticals US INC | $32.12 | 2022-2023 | Quviviq |
| Avion Pharmaceuticals | $28.42 | 2023 | Methylphenidate Hydrochloride |
| Gilead Sciences, INC. | $23.88 | 2024 | Epclusa |
| Almatica Pharma LLC | $23.14 | 2021 | |
| Dexcom, INC. | $20.84 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $19.60 | 2025 | Jardiance |
| Vertex Pharmaceuticals Incorporated | $18.71 | 2025 | |
| Exact Sciences Corporation | $14.98 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Trumble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.